Expertise in
23
conditions

Dr. Prakash Ambady

Neurology
9135 Southwest Barnes Road, Suite 461, 
Portland, OR 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
23
conditions
9135 Southwest Barnes Road, Suite 461, 
Portland, OR 

Overview

Prakash Ambady is a Neurologist practicing medicine in Portland, Oregon.

Dr. Ambady is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, and Brain Tumor.

He is actively involved in clinical research, co-authoring 42 peer reviewed articles and participating in 7 clinical trials. Dr. Ambady is currently accepting new patients.

Specialties

Neurology

Licenses

Psychiatry & Neurology in OR

Hospital Affiliations

Ohsu Hospital And Clinics
Providence Portland Medical Center
Providence St Vincent Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
ATRIO Health
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Moda Health
  • EPO
  • PPO
PacificSource
  • PPO
Prominence Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 5 Less Insurance Carriers -

Locations

9135 Southwest Barnes Road, Suite 461, Portland, OR 97225

Additional Areas of Focus

Dr. Ambady has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

The Feasibility of Steady State CBV Mapping Using Ferumoxytol Immediately After Gadolinium Enhanced MRI of the CNS
The Feasibility of Steady State CBV Mapping Using Ferumoxytol Immediately After Gadolinium Enhanced MRI of the CNS
Enrollment Status: Recruiting
Publish Date: February 27, 2026
Intervention Type: Procedure, Drug
Study Phase: Phase 2
A Phase 2b Trial of the MEK 1/2 Inhibitor (MEKi) PD-0325901 in Adult and Pediatric Patients With Neurofibromatosis Type 1 (NF1)-Associated Inoperable Plexiform Neurofibromas (PNs) That Are Causing Significant Morbidity
A Phase 2b Trial of the MEK 1/2 Inhibitor (MEKi) PD-0325901 in Adult and Pediatric Patients With Neurofibromatosis Type 1 (NF1)-Associated Inoperable Plexiform Neurofibromas (PNs) That Are Causing Significant Morbidity
Enrollment Status: Active_not_recruiting
Publish Date: July 10, 2026
Intervention Type: Drug
Study Drug: Mirdametinib
Study Phase: Phase 2
A Multicenter, Open-Label Study With a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme After Failure of Standard First Line Therapy
A Multicenter, Open-Label Study With a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme After Failure of Standard First Line Therapy
Enrollment Status: Active_not_recruiting
Publish Date: April 15, 2026
Intervention Type: Drug
Study Drugs: Berubicin, Lomustine
Study Phase: Phase 2
Response Assessment to Pembrolizumab With Standard of Care Therapy in Glioblastoma Using Ferumoxytol Steady State Imaging- A Pilot Study
Response Assessment to Pembrolizumab With Standard of Care Therapy in Glioblastoma Using Ferumoxytol Steady State Imaging- A Pilot Study
Enrollment Status: Terminated
Publish Date: September 09, 2025
Intervention Type: Drug, Procedure, Other, Biological
Study Drugs: Ferumoxytol, Pembrolizumab
Study Phase: Phase 2
A Phase 2, Open-label, Single-arm Study Evaluating the Efficacy, Safety and Tolerability of Lerapolturev (PVSRIPO) and the Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of Patients With Recurrent Glioblastoma
A Phase 2, Open-label, Single-arm Study Evaluating the Efficacy, Safety and Tolerability of Lerapolturev (PVSRIPO) and the Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of Patients With Recurrent Glioblastoma
Enrollment Status: Completed
Publish Date: June 05, 2025
Intervention Type: Biological
Study Drugs: PVSRIPO, Pembrolizumab
Study Phase: Phase 2
The Use of Perfusion MRI Using Ferumoxytol and Small Molecular Weight Gadolinium (Gd) Agents to Assess Response to Pembrolizumab in Brain Metastases and Systemic Lesions in NSCLC: A Comparison of Imaging Modalities to Address Brain Metastases, Pseudoprogression, and Systemic Lesion Tumor Flare (Neuro-Check Pilot)
The Use of Perfusion MRI Using Ferumoxytol and Small Molecular Weight Gadolinium (Gd) Agents to Assess Response to Pembrolizumab in Brain Metastases and Systemic Lesions in NSCLC: A Comparison of Imaging Modalities to Address Brain Metastases, Pseudoprogression, and Systemic Lesion Tumor Flare (Neuro-Check Pilot)
Enrollment Status: Terminated
Publish Date: August 10, 2022
Intervention Type: Procedure, Drug, Other, Biological
Study Drug: Ferumoxytol
Study Phase: Phase 2
View 5 Less Clinical Trials

42 Total Publications

Cardiac Monitoring for Patients Undergoing Treatment With MEK Inhibitor Monotherapy.
Cardiac Monitoring for Patients Undergoing Treatment With MEK Inhibitor Monotherapy.
Journal: Current oncology reports
Published: May 05, 2026
Similar Doctors
Expertise in
12
conditions
Expertise in
12
conditions
Referral may be required

University Professional Services

3303 S Bond Ave, 
Portland, OR 
 (4.8 miles away)
503-494-8311
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Marian Dale, MD, specializes in Neurocritical Care. Dr. Dale is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Supranuclear Ophthalmoplegia, Progressive Supranuclear Palsy Atypical, Progressive Supranuclear Palsy, and Movement Disorders. Dr. Dale is currently accepting new patients.

Expertise in
11
conditions
Expertise in
11
conditions
Referral may be required

OHSU Hospital

3181 SW Sam Jackson Park Rd, 
Portland, OR 
 (4.1 miles away)
503-494-7231
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Delaram Safarpour is a Neurologist practicing medicine in Portland, Oregon. Dr. Safarpour is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Movement Disorders, Parkinson's Disease, Essential Tremor, Deep Brain Stimulation, and Thalamotomy. Dr. Safarpour is currently accepting new patients.

Expertise in
23
conditions
Expertise in
23
conditions
Referral may be required

Oregon Health & Science University

3303 S Bond Ave, 
Portland, OR 
 (4.8 miles away)
503-494-7772
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Matthew Brodsky is a Neurologist practicing medicine in Portland, Oregon. Dr. Brodsky is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Drug Induced Dyskinesia, Essential Tremor, and Deep Brain Stimulation. Dr. Brodsky is currently accepting new patients.

Frequently Asked Questions about Dr. Prakash Ambady

How do I make an appointment with Dr. Prakash Ambady?

You can book an appointment with Dr. Prakash Ambady by calling their office at 503-216-1150. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Prakash Ambady a top-rated expert for Astrocytoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Prakash Ambady is classified as an Elite expert for Astrocytoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Prakash Ambady specialize in?

While Dr. Prakash Ambady is a Neurology, they have specific expertise in Astrocytoma, Glioblastoma, and Glioma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Prakash Ambady participate in research or clinical trials?

Yes. Dr. Prakash Ambady has published 42 articles and abstracts on conditions like Astrocytoma. You can view a list of Dr. Prakash Ambady's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Prakash Ambady accept my insurance?

Dr. Prakash Ambady accepts most major insurance plans, including Aetna and ATRIO Health. We recommend calling the office directly at 503-216-1150 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ambady's expertise for a condition
ConditionClose
View All 11 Distinguished Conditions
View All 7 Advanced Conditions
View All 16 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile